Title : [Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11)].

Pub. Date : 1999 May

PMID : 10410150






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Two phase I studies (CIC-therapy) were conducted in advanced non-small cell lung cancer (NSCLC) to determine the maximum tolerable dose (MTD) of CPT-11 combined with cisplatin and ifosfamide, and MTD of cisplatin combined with CPT-11 and ifosfamide with G-CSF support, respectively. Irinotecan colony stimulating factor 3 Homo sapiens